Accelerate Diagnostics Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Accelerate Diagnostics (AXDX) Posts Smaller Q1 Loss
May 16, 2022 4:09 PM EDTAccelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.9 million.
Net cash used in the quarter was $13.2 million, and the company ended the quarter with total... More



